Dimensional Fund Advisors LP Acquires 185,223 Shares of Agilent Technologies, Inc. $A

Dimensional Fund Advisors LP grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 9.6% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 2,108,764 shares of the medical research company’s stock after purchasing an additional 185,223 shares during the period. Dimensional Fund Advisors LP’s holdings in Agilent Technologies were worth $240,336,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after buying an additional 24,687 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares during the period. CCLA Investment Management grew its stake in shares of Agilent Technologies by 1.9% in the fourth quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock worth $142,542,000 after acquiring an additional 19,518 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Agilent Technologies by 20.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock worth $7,269,000 after acquiring an additional 9,236 shares during the last quarter. Finally, Oak Thistle LLC bought a new position in Agilent Technologies during the fourth quarter worth $3,457,000.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on A shares. HSBC reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. TD Cowen upped their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Sanford C. Bernstein started coverage on Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 target price on the stock. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Stock Performance

NYSE:A opened at $139.68 on Friday. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $39.45 billion, a PE ratio of 28.05, a price-to-earnings-growth ratio of 2.37 and a beta of 1.25. The firm has a 50-day moving average price of $129.21 and a 200 day moving average price of $125.46.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.01 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is currently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.